Langballe, Rikke
Frederiksen, Kirsten
Jensen, Maj-Britt
Andersson, Michael
Cronin-Fenton, Deirdre
Ejlertsen, Bent
Mellemkjær, Lene
Funding for this research was provided by:
The Scientific Commitee of the Danish Cancer Society (R90-A5792-14-S2)
Henrik Henriksens Fond
Holger og Inez Petersens Mindelegat
Fru Astrid Thaysens Legat for Lægevidenskabelig Grundforskning
Article History
Received: 28 May 2018
Accepted: 29 May 2018
First Online: 11 June 2018
Compliance with ethical standards
:
: Maj-Britt Jensen has received personal fees and non-financial support from Astra Zeneca, non-financial support from Novartis, and non-financial support from Celgene outside the submitted work. Bent Ejlertsen has received grants from NanoString, Roche, and Novartis outside the submitted work. Lene Mellemkjær has received funding for the study from funding bodies described under ‘Funding.’ All other authors declare that they have no conflict of interest.
: The study was approved by the Data Protection Board. Approvals from Ethical Committees are not needed for registry-based research in Denmark.
: Informed consent is not required for register-based studies in Denmark that do not involve contact with study participants or biological samples.